Nath Bio-Genes (India) Ltd

Nath BioGenes Reports Steady Growth in Q2 2025 📈

- Standalone revenue for Q2 2025: ₹28,017.18 lakhs (14.89% YoY growth)

- Standalone net profit for Q2 2025: ₹3,820.60 lakhs (12.75% YoY growth)

- Consolidated revenue for Q2 2025: ₹28,370.01 lakhs (16.33% YoY growth)

- Consolidated net profit for Q2 2025: ₹3,728.11 lakhs (11.77% YoY growth)

- Earnings per share (EPS): Standalone ₹20.06, Consolidated ₹19.58

- New appointment: Ms. Payal Jain as Additional Director (Independent Director)

- Company operates in Seed Cultivation segment

- Zero investor complaints this quarter